Keywords: king, swings, loss, 1st, qtr, alpharma, costs
King swings to loss in 1st qtr on Alpharma costs
Article | 12 May 2009
King Pharmaceuticals' first-quarter 2009 revenues inched down 0.7% year-on-year to $429.0 million and the US drugmaker swung to a loss of $11.0 million versus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
